Statistics for Lytix Biopharma AS (id:10507 LYTIX)
Valuation metrics
Market cap
372.08M
Enterprise value
232.54M
Trailing P/E (ttm)
-2.67
Forward P/E
-1.60
PEG ratio
-1.60
Price/Sales (ttm)
25.76
Price/Book (mrq)
5.85
Enterprise Value/Revenue
16.10
Enterprise Value/EBITDA
-2.97
Overview
Shares outstanding
49.61M
Float
24.53M
Shares short
% Held by insiders
3.00%
% Held by institutions
0.00%
Average volume (10 days)
107.11K
Average volume (90 days)
Price summary
52-Week low
4.62
52-Week high
15.00
52-Week change
14.73%
Beta
3.00
50-Day moving average
6.64
200-Day moving average
7.38
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
-543.01%
Operational effectiveness
Return on assets
-53.28%
Return on equity
-105.16%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-78,359,000.00
Net income to common (ttm)
-76,419,000.00
Diluted EPS (ttm)
-1.72
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
60.18M
Total cash per share (mrq)
1.21
Total debt (mrq)
3.00M
Total Debt/Equity (mrq)
5.06
Current ratio (mrq)
461.10%
Book value per share (mrq)
1.28
Cash flow
Cash flow statement
-87,156,000.00
Levered free cash flow (LFCF)
-58,675,248.00